Kyverna Therapeutics, Inc To Start Trading Tomorrow

Kyverna Therapeutics, Inc KYTX IPO will take place February, 08 on the NASDAQ exchange under the ticker KYTX.

The company is offering shares at an expected price between $20.00 and $21.00 per share with an insider lock-up period of 180 days ending on August 06, 2024.

See also: Benzinga IPO Calendar

About Kyverna Therapeutics, Inc

Kyverna Therapeutics, Inc is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.